Selected research
Industry Research
Bovine Blood Products Industry Research Report 2026
Market perspective
The global Bovine Blood Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bovine Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bovine Blood Products is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bovine Blood Products is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bovine Blood Products include Animal Technologies, Bio Nutrientes Brasil, Biological Industries, Biowest, Bovogen, Cytiva, ExCell Bio, Gemini and Internegocios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bovine Blood Products market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bovine Blood Products Market by Company
Animal Technologies
Bio Nutrientes Brasil
Biological Industries
Biowest
Bovogen
Cytiva
ExCell Bio
Gemini
Internegocios
Moregate BioTech
NorthBio
PAN-Biotech
Peak Serum
R&D Systems
RMBIO
Serana
Seroxlab
Tissue Culture Biologicals
VWR
WISENT
Corning
Lanzhou Minhai
Merck
Jin Yuan Kang
Thermo Fisher
Zhejiang Tianhang Biotechnology
Bovine Blood Products Segment by Type
Bovine / Cow
Fetal Bovine
Others
Bovine Blood Products Segment by Application
Scientific Research
Industrial Production
Bovine Blood Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bovine Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bovine Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bovine Blood Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bovine Blood Products manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bovine Blood Products by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bovine Blood Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bovine / Cow
- Fetal Bovine
- Others
Applications
- Scientific Research
- Industrial Production
Companies covered
- Animal Technologies
- Bio Nutrientes Brasil
- Biological Industries
- Biowest
- Bovogen
- Cytiva
- ExCell Bio
- Gemini
- Internegocios
- Moregate BioTech
- NorthBio
- PAN-Biotech
- Peak Serum
- R&D Systems
- RMBIO
- Serana
- Seroxlab
- Tissue Culture Biologicals
- VWR
- WISENT
- Corning
- Lanzhou Minhai
- Merck
- Jin Yuan Kang
- Thermo Fisher
- Zhejiang Tianhang Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bovine Blood Products Market Size (2021-2032)
- 2.2.2 Global Bovine Blood Products Sales (2021-2032)
- 2.2.3 Global Bovine Blood Products Market Average Price (2021-2032)
- 2.3 Bovine Blood Products by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Bovine / Cow
- 2.3.3 Fetal Bovine
- 2.3.4 Others
- 2.4 Bovine Blood Products by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Scientific Research
- 2.4.3 Industrial Production
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bovine Blood Products Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bovine Blood Products Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Bovine Blood Products Revenue of Manufacturers (2021-2026)
- 3.4 Global Bovine Blood Products Average Price by Manufacturers (2021-2026)
- 3.5 Global Bovine Blood Products Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bovine Blood Products, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bovine Blood Products, Product Type & Application
- 3.8 Global Manufacturers of Bovine Blood Products, Established Date
- 3.9 Global Bovine Blood Products Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Animal Technologies
- 4.1.1 Animal Technologies Company Information
- 4.1.2 Animal Technologies Business Overview
- 4.1.3 Animal Technologies Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Animal Technologies Bovine Blood Products Product Portfolio
- 4.1.5 Animal Technologies Recent Developments
- 4.2 Bio Nutrientes Brasil
- 4.2.1 Bio Nutrientes Brasil Company Information
- 4.2.2 Bio Nutrientes Brasil Business Overview
- 4.2.3 Bio Nutrientes Brasil Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio Nutrientes Brasil Bovine Blood Products Product Portfolio
- 4.2.5 Bio Nutrientes Brasil Recent Developments
- 4.3 Biological Industries
- 4.3.1 Biological Industries Company Information
- 4.3.2 Biological Industries Business Overview
- 4.3.3 Biological Industries Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biological Industries Bovine Blood Products Product Portfolio
- 4.3.5 Biological Industries Recent Developments
- 4.4 Biowest
- 4.4.1 Biowest Company Information
- 4.4.2 Biowest Business Overview
- 4.4.3 Biowest Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Biowest Bovine Blood Products Product Portfolio
- 4.4.5 Biowest Recent Developments
- 4.5 Bovogen
- 4.5.1 Bovogen Company Information
- 4.5.2 Bovogen Business Overview
- 4.5.3 Bovogen Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Bovogen Bovine Blood Products Product Portfolio
- 4.5.5 Bovogen Recent Developments
- 4.6 Cytiva
- 4.6.1 Cytiva Company Information
- 4.6.2 Cytiva Business Overview
- 4.6.3 Cytiva Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cytiva Bovine Blood Products Product Portfolio
- 4.6.5 Cytiva Recent Developments
- 4.7 ExCell Bio
- 4.7.1 ExCell Bio Company Information
- 4.7.2 ExCell Bio Business Overview
- 4.7.3 ExCell Bio Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ExCell Bio Bovine Blood Products Product Portfolio
- 4.7.5 ExCell Bio Recent Developments
- 4.8 Gemini
- 4.8.1 Gemini Company Information
- 4.8.2 Gemini Business Overview
- 4.8.3 Gemini Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Gemini Bovine Blood Products Product Portfolio
- 4.8.5 Gemini Recent Developments
- 4.9 Internegocios
- 4.9.1 Internegocios Company Information
- 4.9.2 Internegocios Business Overview
- 4.9.3 Internegocios Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Internegocios Bovine Blood Products Product Portfolio
- 4.9.5 Internegocios Recent Developments
- 4.10 Moregate BioTech
- 4.10.1 Moregate BioTech Company Information
- 4.10.2 Moregate BioTech Business Overview
- 4.10.3 Moregate BioTech Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Moregate BioTech Bovine Blood Products Product Portfolio
- 4.10.5 Moregate BioTech Recent Developments
- 4.11 NorthBio
- 4.11.1 NorthBio Company Information
- 4.11.2 NorthBio Business Overview
- 4.11.3 NorthBio Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 NorthBio Bovine Blood Products Product Portfolio
- 4.11.5 NorthBio Recent Developments
- 4.12 PAN-Biotech
- 4.12.1 PAN-Biotech Company Information
- 4.12.2 PAN-Biotech Business Overview
- 4.12.3 PAN-Biotech Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 PAN-Biotech Bovine Blood Products Product Portfolio
- 4.12.5 PAN-Biotech Recent Developments
- 4.13 Peak Serum
- 4.13.1 Peak Serum Company Information
- 4.13.2 Peak Serum Business Overview
- 4.13.3 Peak Serum Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Peak Serum Bovine Blood Products Product Portfolio
- 4.13.5 Peak Serum Recent Developments
- 4.14 R&D Systems
- 4.14.1 R&D Systems Company Information
- 4.14.2 R&D Systems Business Overview
- 4.14.3 R&D Systems Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 R&D Systems Bovine Blood Products Product Portfolio
- 4.14.5 R&D Systems Recent Developments
- 4.15 RMBIO
- 4.15.1 RMBIO Company Information
- 4.15.2 RMBIO Business Overview
- 4.15.3 RMBIO Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 RMBIO Bovine Blood Products Product Portfolio
- 4.15.5 RMBIO Recent Developments
- 4.16 Serana
- 4.16.1 Serana Company Information
- 4.16.2 Serana Business Overview
- 4.16.3 Serana Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Serana Bovine Blood Products Product Portfolio
- 4.16.5 Serana Recent Developments
- 4.17 Seroxlab
- 4.17.1 Seroxlab Company Information
- 4.17.2 Seroxlab Business Overview
- 4.17.3 Seroxlab Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Seroxlab Bovine Blood Products Product Portfolio
- 4.17.5 Seroxlab Recent Developments
- 4.18 Tissue Culture Biologicals
- 4.18.1 Tissue Culture Biologicals Company Information
- 4.18.2 Tissue Culture Biologicals Business Overview
- 4.18.3 Tissue Culture Biologicals Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Tissue Culture Biologicals Bovine Blood Products Product Portfolio
- 4.18.5 Tissue Culture Biologicals Recent Developments
- 4.19 VWR
- 4.19.1 VWR Company Information
- 4.19.2 VWR Business Overview
- 4.19.3 VWR Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 VWR Bovine Blood Products Product Portfolio
- 4.19.5 VWR Recent Developments
- 4.20 WISENT
- 4.20.1 WISENT Company Information
- 4.20.2 WISENT Business Overview
- 4.20.3 WISENT Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 WISENT Bovine Blood Products Product Portfolio
- 4.20.5 WISENT Recent Developments
- 4.21 Corning
- 4.21.1 Corning Company Information
- 4.21.2 Corning Business Overview
- 4.21.3 Corning Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Corning Bovine Blood Products Product Portfolio
- 4.21.5 Corning Recent Developments
- 4.22 Lanzhou Minhai
- 4.22.1 Lanzhou Minhai Company Information
- 4.22.2 Lanzhou Minhai Business Overview
- 4.22.3 Lanzhou Minhai Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.22.4 Lanzhou Minhai Bovine Blood Products Product Portfolio
- 4.22.5 Lanzhou Minhai Recent Developments
- 4.23 Merck
- 4.23.1 Merck Company Information
- 4.23.2 Merck Business Overview
- 4.23.3 Merck Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.23.4 Merck Bovine Blood Products Product Portfolio
- 4.23.5 Merck Recent Developments
- 4.24 Jin Yuan Kang
- 4.24.1 Jin Yuan Kang Company Information
- 4.24.2 Jin Yuan Kang Business Overview
- 4.24.3 Jin Yuan Kang Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.24.4 Jin Yuan Kang Bovine Blood Products Product Portfolio
- 4.24.5 Jin Yuan Kang Recent Developments
- 4.25 Thermo Fisher
- 4.25.1 Thermo Fisher Company Information
- 4.25.2 Thermo Fisher Business Overview
- 4.25.3 Thermo Fisher Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.25.4 Thermo Fisher Bovine Blood Products Product Portfolio
- 4.25.5 Thermo Fisher Recent Developments
- 4.26 Zhejiang Tianhang Biotechnology
- 4.26.1 Zhejiang Tianhang Biotechnology Company Information
- 4.26.2 Zhejiang Tianhang Biotechnology Business Overview
- 4.26.3 Zhejiang Tianhang Biotechnology Bovine Blood Products Sales, Revenue and Gross Margin (2021-2026)
- 4.26.4 Zhejiang Tianhang Biotechnology Bovine Blood Products Product Portfolio
- 4.26.5 Zhejiang Tianhang Biotechnology Recent Developments
5 Global Bovine Blood Products Market Scenario by Region
- 5.1 Global Bovine Blood Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bovine Blood Products Sales by Region: 2021-2032
- 5.2.1 Global Bovine Blood Products Sales by Region: 2021-2026
- 5.2.2 Global Bovine Blood Products Sales by Region: 2027-2032
- 5.3 Global Bovine Blood Products Revenue by Region: 2021-2032
- 5.3.1 Global Bovine Blood Products Revenue by Region: 2021-2026
- 5.3.2 Global Bovine Blood Products Revenue by Region: 2027-2032
- 5.4 North America Bovine Blood Products Market Facts & Figures by Country
- 5.4.1 North America Bovine Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bovine Blood Products Sales by Country (2021-2032)
- 5.4.3 North America Bovine Blood Products Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Bovine Blood Products Market Facts & Figures by Country
- 5.5.1 Europe Bovine Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bovine Blood Products Sales by Country (2021-2032)
- 5.5.3 Europe Bovine Blood Products Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Bovine Blood Products Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bovine Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bovine Blood Products Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bovine Blood Products Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bovine Blood Products Market Facts & Figures by Country
- 5.7.1 South America Bovine Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bovine Blood Products Sales by Country (2021-2032)
- 5.7.3 South America Bovine Blood Products Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Bovine Blood Products Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bovine Blood Products Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bovine Blood Products Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bovine Blood Products Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Bovine Blood Products Sales by Type (2021-2032)
- 6.1.1 Global Bovine Blood Products Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Bovine Blood Products Sales Market Share by Type (2021-2032)
- 6.2 Global Bovine Blood Products Revenue by Type (2021-2032)
- 6.2.1 Global Bovine Blood Products Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bovine Blood Products Revenue Market Share by Type (2021-2032)
- 6.3 Global Bovine Blood Products Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bovine Blood Products Sales by Application (2021-2032)
- 7.1.1 Global Bovine Blood Products Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Bovine Blood Products Sales Market Share by Application (2021-2032)
- 7.2 Global Bovine Blood Products Revenue by Application (2021-2032)
- 7.2.1 Global Bovine Blood Products Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bovine Blood Products Revenue Market Share by Application (2021-2032)
- 7.3 Global Bovine Blood Products Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bovine Blood Products Value Chain Analysis
- 8.1.1 Bovine Blood Products Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bovine Blood Products Production Mode & Process
- 8.2 Bovine Blood Products Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bovine Blood Products Distributors
- 8.2.3 Bovine Blood Products Customers
9 Global Bovine Blood Products Analyzing Market Dynamics
- 9.1 Bovine Blood Products Industry Trends
- 9.2 Bovine Blood Products Industry Drivers
- 9.3 Bovine Blood Products Industry Opportunities and Challenges
- 9.4 Bovine Blood Products Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst